면역학

La Trobe University researchers say dying cells can leave behind a residue containing newly identified extracellular vesicles that help direct immune clearance, but laboratory experiments suggest influenza viruses may also use the vesicles to help spread.

2026년 06월 04일 AI에 의해 보고됨 사실 확인됨

Cancer cells that reduce MHC class I—a common way to evade CD8+ “killer” T cells—may become more vulnerable to destruction by CD4+ “helper” T cells through ferroptosis, according to research led by Baylor College of Medicine and collaborators at the University of Michigan and published in Nature Immunology.

Researchers have developed a genomic mapping technique that reveals how thousands of genes work together to influence disease risk, helping to bridge gaps left by traditional genetic studies. The approach, described in a Nature paper led by Gladstone Institutes and Stanford University scientists, combines large-scale cell experiments with population genetics data to highlight promising targets for future therapies and deepen understanding of conditions such as blood disorders and immune-mediated diseases.

2025년 12월 15일 AI에 의해 보고됨

절강대학교 연구원들이 일반적으로 알레르기에 관여하는 비만세포를 재프로그래밍하여 암 싸움 바이러스를 종양에 직접 전달하는 새로운 방법을 개발했다. 최근 《셀》 저널 연구에서 상세히 설명된 이 접근법은 면역 반응을 강화하고 동물 모델에서 유망한 결과를 보인다. 이는 개인화된 암 치료를 위한 길을 열어준다.

A new study reveals that breastfeeding leads to a long-term surge in specialized immune cells in breast tissue, potentially reducing cancer risk. Researchers found these CD8+ T cells persist for decades, acting as guards against malignant cells. The findings suggest breastfeeding could enhance natural protection against aggressive breast cancers.

2025년 10월 16일 AI에 의해 보고됨

Scientists have developed mRNA vaccines that produce virus-like nanoparticles inside cells, potentially offering more robust immune responses than current versions. In mouse studies, this approach generated antibody levels up to 28 times higher than standard mRNA vaccines. The innovation could reduce side effects by allowing lower doses while maintaining efficacy.